Frankenfeld, F.; Wagmann, L.; Abelian, A.; Wallach, J.; Adejare, A.; Brandt, S.D.; Meyer, M.R.
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites 2024, 14, 270.
https://doi.org/10.3390/metabo14050270
AMA Style
Frankenfeld F, Wagmann L, Abelian A, Wallach J, Adejare A, Brandt SD, Meyer MR.
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites. 2024; 14(5):270.
https://doi.org/10.3390/metabo14050270
Chicago/Turabian Style
Frankenfeld, Fabian, Lea Wagmann, Anush Abelian, Jason Wallach, Adeboye Adejare, Simon D. Brandt, and Markus R. Meyer.
2024. "In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry" Metabolites 14, no. 5: 270.
https://doi.org/10.3390/metabo14050270
APA Style
Frankenfeld, F., Wagmann, L., Abelian, A., Wallach, J., Adejare, A., Brandt, S. D., & Meyer, M. R.
(2024). In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry. Metabolites, 14(5), 270.
https://doi.org/10.3390/metabo14050270